Courtney Qualls
Nurse Practitioner · Troy, ALNPI 1275218307
Payments from drug & device makers
Across 72 payments — averaging $18.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$319
- Lexicon Pharmaceuticals, Inc.$216
- Merck$133
- AstraZeneca$106
- Bayer$67
- Johnson & Johnson$59
- plus $467 from 17 others
What the payments were for
- Food & beverage$1,368100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 20 | $319 |
| Lexicon Pharmaceuticals, Inc. | 8 | $216 |
| Merck | 8 | $133 |
| AstraZeneca | 6 | $106 |
| Bayer | 3 | $67 |
| Johnson & Johnson | 3 | $59 |
| Pfizer | 3 | $50 |
| Incyte Corporation | 2 | $45 |
| Eisai Inc. | 2 | $39 |
| Novo Nordisk | 2 | $38 |
| AbbVie | 1 | $36 |
| Amgen | 2 | $32 |
| Medtronic | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Pharmaessentia USA Corporation | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Novartis | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Irhythm Technologies, Inc. | 1 | $19 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $17 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
How this compares
$1,368 in reported general payments places this provider in the 75th percentile of 1,505 nurse practitioner providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 42 | $34,268 |
| EntrestoSacubitril/Valsartan | 32 | $29,353 |
| FarxigaDapagliflozin Propanediol | 19 | $16,579 |
| Metoprolol Succinate | 65 | $769 |
| Ranolazine ErRanolazine | 12 | $582 |
| Cephalexin | 78 | $518 |
| Carvedilol | 23 | $289 |
| Hydralazine Hcl | 14 | $279 |
| Amlodipine Besylate | 38 | $223 |
| Losartan Potassium | 19 | $200 |
| Atorvastatin Calcium | 15 | $182 |
| Metoprolol Tartrate | 22 | $181 |
| Nitroglycerin | 11 | $126 |
| ClopidogrelClopidogrel Bisulfate | 13 | $118 |
| Spironolactone | 13 | $98 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $50 | $34,26842 claims |
| NovartisEntresto | $19 | $29,35332 claims |
| AstraZenecaFarxiga | $106 | $16,57919 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,505 nurse practitioner providers in Alabama.
Other nurse practitioner in Troy
- Erin TannerAlabaster$141K
- Ardie Pack MabienMobile$126K
- Ginger McDanielBirmingham$27K
- Audrey MorganMontgomery$24K
- Hollie CrutchfieldDothan$22K
- Leah GravesBirmingham$21K
- Lauren DowneyBirmingham$19K
- Ashley HodgensMontgomery$19K
- Lisa PeoplesBirmingham$17K
- Samantha WeaverBirmingham$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.